Clinical Trial Update: JUMP Prevalence of Sarcopenia and Chemobrain in Post-cancer Patients

View source ↗

Summary

A clinical trial update for the JUMP study assessing the prevalence of sarcopenia and chemotherapy-related cognitive impairment in post-cancer patients; recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Cognitive Impairment
• Sarcopenia

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Cancer, Sarcopenia | Status: RECRUITING